1. Home
  2. TXG vs GRDN Comparison

TXG vs GRDN Comparison

Compare TXG & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • GRDN
  • Stock Information
  • Founded
  • TXG 2012
  • GRDN 2004
  • Country
  • TXG United States
  • GRDN United States
  • Employees
  • TXG N/A
  • GRDN N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • GRDN Retail-Drug Stores and Proprietary Stores
  • Sector
  • TXG Industrials
  • GRDN Consumer Staples
  • Exchange
  • TXG Nasdaq
  • GRDN Nasdaq
  • Market Cap
  • TXG 1.3B
  • GRDN 1.3B
  • IPO Year
  • TXG 2019
  • GRDN 2024
  • Fundamental
  • Price
  • TXG $14.11
  • GRDN $20.54
  • Analyst Decision
  • TXG Buy
  • GRDN Strong Buy
  • Analyst Count
  • TXG 12
  • GRDN 2
  • Target Price
  • TXG $14.13
  • GRDN $24.50
  • AVG Volume (30 Days)
  • TXG 3.7M
  • GRDN 212.2K
  • Earning Date
  • TXG 08-07-2025
  • GRDN 08-11-2025
  • Dividend Yield
  • TXG N/A
  • GRDN N/A
  • EPS Growth
  • TXG N/A
  • GRDN N/A
  • EPS
  • TXG N/A
  • GRDN N/A
  • Revenue
  • TXG $624,662,000.00
  • GRDN $1,282,307,000.00
  • Revenue This Year
  • TXG N/A
  • GRDN $11.93
  • Revenue Next Year
  • TXG $5.69
  • GRDN $2.18
  • P/E Ratio
  • TXG N/A
  • GRDN N/A
  • Revenue Growth
  • TXG N/A
  • GRDN 19.55
  • 52 Week Low
  • TXG $6.78
  • GRDN $14.16
  • 52 Week High
  • TXG $24.76
  • GRDN $26.91
  • Technical
  • Relative Strength Index (RSI)
  • TXG 68.91
  • GRDN N/A
  • Support Level
  • TXG $11.45
  • GRDN N/A
  • Resistance Level
  • TXG $14.16
  • GRDN N/A
  • Average True Range (ATR)
  • TXG 0.71
  • GRDN 0.00
  • MACD
  • TXG 0.08
  • GRDN 0.00
  • Stochastic Oscillator
  • TXG 93.01
  • GRDN 0.00

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

Share on Social Networks: